Tersigni Vision is drawing attention to a critical credential that sets its founder, Dr. Steven Tersigni, apart in the field ...
Rice hosted the second Advanced Research Projects Agency for Health Biohybrid Devices Summit Sept. 25-26 in Houston to ...
The global market for Subcutaneous Implantable Defibrillator Systems is projected to experience robust growth over the next ...
Mechanical vacuum aspiration to debulk lead-associated vegetations during lead extraction appears feasible and safe and ...
Yunqi Capital Limited (together with its affiliates and the funds it advises, "Yunqi Capital"), an investment management firm and 5.1% shareholder of STAAR Surgical Company ("STAAR" or the "Company") ...
Samsara Vision, a company focused on bringing vision and freedom back to patients with late-stage, age-related macular degeneration (AMD) through advanced visual prosthetic devices, today announced ...
Lake Oswego, OR October 02, 2025 – PRESSADVANTAGE – Tersigni Vision has published new guidance addressing a common concern ...
Are you itching to catch presentations from the Ophthalmology Times® editorial advisory board? Twenty of our esteemed ...
Implantable biosensors and wearable technologies have the potential to enable continuous, real-time monitoring of kidney and ...
Comphya SA, a clinical-stage MedTech company pioneering the first implantable neurostimulation therapy for erectile dysfunction (ED) unresponsive to medication, today announced that the first patient ...
HOUSTON, TX – With advancing vision correction technologies, many patients find themselves facing a crucial decision: LASIK or EVO ICL. Houston LASIK & Eye, under the leadership of Dr. Amjad Khokhar, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback